4-[[2-[2-[2-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]ethoxy]ethoxy]acetyl]amino]-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide

InChIKey	`PTJNYVXLFRBJGN-UHFFFAOYSA-N`
Compound Name	4-[[2-[2-[2-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]ethoxy]ethoxy]acetyl]amino]-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide
Canonical SMILES	`O=C(CCCCCCNC(=O)c1ccc(NC(=O)COCCOCCNC(=O)COc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)cc1)NO`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	5
Pfam Stratification	Cross-Family
Avg pChEMBL	7.06
Source	ChEMBL

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
Q9UBN7	HDAC6	Homo sapiens	Human	PF00850 PF02148	7.6	IC50	ChEMBL
O15379	HDAC3	Homo sapiens	Human	PF00850	7.2	IC50	ChEMBL
Q96SW2	CRBN	Homo sapiens	Human	PF02190 PF03226	7.2	IC50	ChEMBL
Q13547	HDAC1	Homo sapiens	Human	PF00850	6.8	IC50	ChEMBL
Q92769	HDAC2	Homo sapiens	Human	PF00850	6.6	IC50	ChEMBL